We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
(+11%)
Cap. Flow
-$707M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$99.9M |
| 2 |
Uber
UBER
|
+$71M |
| 3 |
Broadcom
AVGO
|
+$36.2M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$32.6M |
| 5 |
lululemon athletica
LULU
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$139M |
| 2 |
Apple
AAPL
|
+$72.7M |
| 3 |
VMW
VMware, Inc
VMW
|
+$47.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$42.3M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$35.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Financials | 13% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Finance of America Companies
FOA
$198M
| $77.2K | ﹤0.01% |
7,020
+359
| +5% | +$3.69K |
|
3252
Orchestra BioMed
OBIO
$254M
| $76.9K | ﹤0.01% |
8,428
+874
| +12% | +$5.97K |
|
3253
Priority Technology Holdings
PRTH
$444M
| $76.5K | ﹤0.01% |
21,480
+276
| +1% | +$928 |
|
3254
Outlook Therapeutics
OTLK
$191M
| $76.4K | ﹤0.01% |
9,692
| – | – |
|
3255
Veritone
VERI
$122M
| $75.8K | ﹤0.01% |
41,893
-7,977
| -16% | -$17.8K |
|
3256
Vista Energy
VIST
$7.32B
| $75.4K | ﹤0.01% |
2,554
-8,628
| -77% | -$254K |
|
3257
Paysign
PAYS
$705M
| $74.7K | ﹤0.01% |
26,680
-498
| -2% | -$1.09K |
|
|
GOCO
3258
DELISTED
GoHealth
GOCO
| $74.7K | ﹤0.01% |
5,597
-186
| -3% | -$2.54K |
|
3259
Atara Biotherapeutics
ATRA
$76.1M
| $74.6K | ﹤0.01% |
5,817
-2
| -0% | -$47 |
|
|
AKTS
3260
DELISTED
Akoustis Technologies Inc
AKTS
| $74.5K | ﹤0.01% |
89,353
| – | – |
|
3261
KORU Medical Systems
KRMD
$164M
| $74.1K | ﹤0.01% |
30,202
| – | – |
|
|
HHR
3262
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
| $74.1K | ﹤0.01% |
4,932
| – | – |
|
3263
Brookfield Asset Management
BAM
$83.8B
| $74.1K | ﹤0.01% |
1,844
| – | – |
|
3264
Urban One Class D
UONEK
$23.8M
| $73.1K | ﹤0.01% |
2,072
-781
| -27% | -$35.7K |
|
|
NOTE
3265
DELISTED
FiscalNote
NOTE
| $73K | ﹤0.01% |
5,337
| – | – |
|
3266
374Water
SCWO
$37.6M
| $72.8K | ﹤0.01% |
5,124
+91
| +2% | +$1.22K |
|
3267
Value Line
VALU
$361M
| $71.1K | ﹤0.01% |
1,458
+22
| +2% | +$938 |
|
|
ALAR
3268
Alarum Technologies
ALAR
$14.3M
| $70.5K | ﹤0.01% |
9,087
-2,540
| -22% | -$11K |
|
|
CNF
3269
CNFinance Holdings
CNF
$37.3M
| $70K | ﹤0.01% |
3,152
| – | – |
|
3270
5E Advanced Materials
FEAM
$62.3M
| $70K | ﹤0.01% |
2,158
+28
| +1% | +$1.36K |
|
3271
Zura Bio
ZURA
$566M
| $69.9K | ﹤0.01% |
14,967
+3,768
| +34% | +$18.8K |
|
3272
Biote Corp
BTMD
$44.9M
| $69.5K | ﹤0.01% |
14,080
| – | – |
|
|
DZSI
3273
DELISTED
DZS Inc. Common Stock
DZSI
| $69.1K | ﹤0.01% |
35,072
+714
| +2% | +$1.12K |
|
3274
Trevi Therapeutics
TRVI
$2.64B
| $69K | ﹤0.01% |
51,464
-2,808
| -5% | -$4.25K |
|
3275
HireQuest
HQI
$185M
| $68.8K | ﹤0.01% |
4,485
+61
| +1% | +$933 |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
- RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
- RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
- RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.